Indeed, phosphorylated SQSTM1/p62 has been shown to accumulate in the HCC tumor region, while its inhibitor may inhibit cell proliferation and resistance to anticancer agents [37]. The gene discussed is SQSTM1; the disease is hepatocellular carcinoma.